Blood Transfusion Diagnostics Market Size, Share, Trends, Growth Outlook

Blood Transfusion Diagnostics Market is estimated to increase at a growth rate of 6.3% CAGR over the forecast period from 2024 to 2030.

The Blood Transfusion Diagnostics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Reagents & kits, Instruments, Others), By Application (Blood grouping, Disease screening), By End-User (Hospitals, Blood banks, Diagnostics laboratories, Others).

 

An Introduction to Blood Transfusion Diagnostics Market in 2024

The Blood Transfusion Diagnostics market in 2024 addresses the demand for advanced diagnostic tests and technologies used in blood banks and transfusion centers to ensure the safety, compatibility, and quality of blood products for transfusion therapy. Blood transfusion diagnostics encompass pre-transfusion testing, blood grouping and typing, antibody screening, infectious disease screening, and donor testing, aimed at identifying and preventing adverse reactions and transfusion-related complications in recipients. Market dynamics are driven by factors such as the increasing demand for blood transfusions in surgical and medical procedures, advancements in blood typing and antibody detection technology, and regulatory mandates for blood safety and quality control. Collaboration between diagnostic companies, blood banks, and regulatory agencies drives innovation and market growth in blood transfusion diagnostics, supporting safe and reliable blood supply chains and transfusion medicine practices worldwide.

 

Blood Transfusion Diagnostics Market Trend: Increasing Demand for Blood Safety and Quality Assurance

A prominent trend in the Blood Transfusion Diagnostics market is the increasing demand for blood safety and quality assurance measures. With rising awareness about the risks associated with blood transfusions, including transmission of infectious diseases and adverse reactions, there is a growing emphasis on implementing stringent screening protocols and diagnostic tests to ensure the safety and quality of donated blood. This trend is driving the adoption of advanced blood transfusion diagnostics solutions that offer rapid and accurate detection of infectious agents, blood group typing, and compatibility testing, thereby enhancing the overall safety and efficacy of blood transfusion procedures.

Blood Transfusion Diagnostics Market Driver: Rising Blood Transfusion Rates and Blood Supply Shortages

A key driver for the Blood Transfusion Diagnostics market is the rising demand for blood transfusions coupled with blood supply shortages. Blood transfusions are essential medical procedures used in various healthcare settings to treat patients suffering from trauma, surgery, cancer, anemia, and other medical conditions. As the global population grows, ages, and becomes more susceptible to chronic diseases, the demand for blood transfusions is expected to increase. However, blood supply shortages, particularly in developing countries and during emergencies or natural disasters, pose significant challenges to meeting this demand. This drives the need for efficient blood transfusion diagnostics to optimize blood utilization, minimize wastage, and ensure safe and timely transfusion practices.

Blood Transfusion Diagnostics Market Opportunity: Adoption of Molecular Diagnostics and Automation Technologies

One potential opportunity in the Blood Transfusion Diagnostics market lies in the adoption of molecular diagnostics and automation technologies. Molecular diagnostics, including nucleic acid amplification tests (NAATs) and next-generation sequencing (NGS), offer high sensitivity and specificity for detecting infectious agents such as HIV, hepatitis B and C viruses, and emerging pathogens like Zika virus and SARS-CoV-2. Integrating molecular diagnostic assays into blood transfusion screening workflows can enhance the detection of bloodborne pathogens and improve blood safety. Furthermore, automation technologies such as robotics, liquid handling systems, and laboratory information management systems (LIMS) can streamline blood transfusion diagnostics processes, reduce turnaround times, and enhance laboratory efficiency, thus presenting opportunities for market expansion and innovation.

 

Blood Transfusion Diagnostics Market Segmentation

By Product

Reagents & kits

Instruments

Others

By Application

Blood grouping

Disease screening

By End-user

Hospitals

Blood banks

Diagnostics laboratories

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Blood Transfusion Diagnostics Market Companies

Abbott

Beckman Coulter

BIOMERIEUX

Bio-Rad Laboratories Inc

F.Hoffman-La Roche AG

Grifols

MedGenome

Ortho Clinical Diagnostics

Quotient Ltd

Siemens Healthcare Private Ltd

*- List Not Exhaustive

 

Reasons to Buy the Blood Transfusion Diagnostics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Blood Transfusion Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Blood Transfusion Diagnostics Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Blood Transfusion Diagnostics Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Blood Transfusion Diagnostics Market Size Outlook, $ Million, 2021 to 2030

3.2 Blood Transfusion Diagnostics Market Outlook by Type, $ Million, 2021 to 2030

3.3 Blood Transfusion Diagnostics Market Outlook by Product, $ Million, 2021 to 2030

3.4 Blood Transfusion Diagnostics Market Outlook by Application, $ Million, 2021 to 2030

3.5 Blood Transfusion Diagnostics Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Blood Transfusion Diagnostics Market Industry

4.2 Key Market Trends in Blood Transfusion Diagnostics Market Industry

4.3 Potential Opportunities in Blood Transfusion Diagnostics Market Industry

4.4 Key Challenges in Blood Transfusion Diagnostics Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Blood Transfusion Diagnostics Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Blood Transfusion Diagnostics Market Outlook By Segments

7.1 Blood Transfusion Diagnostics Market Outlook by Segments

By Product

Reagents & kits

Instruments

Others

By Application

Blood grouping

Disease screening

By End-user

Hospitals

Blood banks

Diagnostics laboratories

Others

 

8 North America Blood Transfusion Diagnostics Market Analysis And Outlook To 2030

8.1 Introduction to North America Blood Transfusion Diagnostics Markets in 2024

8.2 North America Blood Transfusion Diagnostics Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Blood Transfusion Diagnostics Market size Outlook by Segments, 2021-2030

By Product

Reagents & kits

Instruments

Others

By Application

Blood grouping

Disease screening

By End-user

Hospitals

Blood banks

Diagnostics laboratories

Others

 

9 Europe Blood Transfusion Diagnostics Market Analysis And Outlook To 2030

9.1 Introduction to Europe Blood Transfusion Diagnostics Markets in 2024

9.2 Europe Blood Transfusion Diagnostics Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Blood Transfusion Diagnostics Market Size Outlook By Segments, 2021-2030

By Product

Reagents & kits

Instruments

Others

By Application

Blood grouping

Disease screening

By End-user

Hospitals

Blood banks

Diagnostics laboratories

Others

 

10 Asia Pacific Blood Transfusion Diagnostics Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Blood Transfusion Diagnostics Markets in 2024

10.2 Asia Pacific Blood Transfusion Diagnostics Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Blood Transfusion Diagnostics Market size Outlook by Segments, 2021-2030

By Product

Reagents & kits

Instruments

Others

By Application

Blood grouping

Disease screening

By End-user

Hospitals

Blood banks

Diagnostics laboratories

Others

 

11 South America Blood Transfusion Diagnostics Market Analysis And Outlook To 2030

11.1 Introduction to South America Blood Transfusion Diagnostics Markets in 2024

11.2 South America Blood Transfusion Diagnostics Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Blood Transfusion Diagnostics Market size Outlook by Segments, 2021-2030

By Product

Reagents & kits

Instruments

Others

By Application

Blood grouping

Disease screening

By End-user

Hospitals

Blood banks

Diagnostics laboratories

Others

 

12 Middle East And Africa Blood Transfusion Diagnostics Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Blood Transfusion Diagnostics Markets in 2024

12.2 Middle East and Africa Blood Transfusion Diagnostics Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Blood Transfusion Diagnostics Market size Outlook by Segments, 2021-2030

By Product

Reagents & kits

Instruments

Others

By Application

Blood grouping

Disease screening

By End-user

Hospitals

Blood banks

Diagnostics laboratories

Others

 

13 Company Profiles

13.1 Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Abbott

Beckman Coulter

BIOMERIEUX

Bio-Rad Laboratories Inc

F.Hoffman-La Roche AG

Grifols

MedGenome

Ortho Clinical Diagnostics

Quotient Ltd

Siemens Healthcare Private Ltd

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Blood Transfusion Diagnostics Market Segmentation

 

By Product

Reagents & kits

Instruments

Others

By Application

Blood grouping

Disease screening

By End-user

Hospitals

Blood banks

Diagnostics laboratories

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)